Evogene grants director Leon Recanati 2,500 options
The options vest at 25% per quarter beginning September 4, 2026, and will be fully vested on September 4, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Evogene Ltd. (EVGN) granted director Leon Recanati 2,500 stock options on September 4, 2026, with an exercise price of $0.58 per ordinary share. The options were granted under Evogene's 2021 Share Incentive Plan and vest quarterly at 25% per quarter beginning September 4, 2026, becoming fully vested September 4, 2027. They expire September 4, 2036. A separate informational holding entry lists 1,343,886 ordinary shares held directly.
Insider Trade Summary
Grant/Award: 2,500 shares
Grant/Award
12 txns
Insider
RECANATI LEON
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F2, F3, F4 | 2,500 | $0.00 | $0.00 |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Stock Option (right to buy) F1 | -- | -- | -- |
| holding | Ordinary Shares F1 | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 13,450 contracts for 10,950 underlying shares (Direct);
Ordinary Shares — 1,343,886 shares (Direct)
Footnotes (4)
- F1. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F2. The exercise price of the options to purchase Ordinary Shares of the Issuer (the "Options") reported in this row is New Israeli Shekels ("NIS") 1.75 per share, which is equivalent to $0.58 per share based on the representative exchange rate of NIS 3.0050 per U.S. dollar published by the Bank of Israel on September 4, 2026, the grant date.
- F3. The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 2,500 Options. The Options were granted pursuant to, and are subject to the terms of, the Issuer's 2021 Share Incentive Plan,
- F4. The Options vest and become exercisable on a quarterly basis (25% per quarter), commencing on September 4, 2026, such that the Options will be fully vested on September 4, 2027, the one-year anniversary of the grant date.
Key Figures
Options granted: 2,500 options
Exercise price: $0.58 per ordinary share
Vesting rate: 25% per quarter
+3 more
6 metrics
Options granted
2,500 options
Granted to director Leon Recanati on September 4, 2026
Exercise price
$0.58 per ordinary share
Price for the options granted September 4, 2026
Vesting rate
25% per quarter
Vesting begins September 4, 2026
Full vesting date
September 4, 2027
Date the options will be fully vested
Option expiration date
September 4, 2036
Expiration date for the newly granted options
Ordinary shares held directly
1,343,886 shares
Informational holding entry
Key Terms
exercise price, 2021 Share Incentive Plan, vest, representative exchange rate
4 terms
exercise price financial
"The exercise price of the options to purchase Ordinary Shares"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"vest and become exercisable on a quarterly basis"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
representative exchange rate financial
"based on the representative exchange rate of NIS 3.0050 per U.S. dollar"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did EVGN director Leon Recanati receive?
Leon Recanati received a grant of 2,500 stock options on September 4, 2026, with an exercise price of $0.58 per ordinary share. The grant was under Evogene's 2021 Share Incentive Plan.
When do Leon Recanati's EVGN options vest and expire?
The options vest and become exercisable quarterly at 25% per quarter, beginning September 4, 2026, and will be fully vested on September 4, 2027. Their expiration date is September 4, 2036.
AI-generated analysis. How Rhea-AI works. Not financial advice.
